Last reviewed · How we verify

budesonide 400 mcg

Hamilton Health Sciences Corporation · FDA-approved active Small molecule Quality 2/100

budesonide 400 mcg is a Small molecule drug developed by Hamilton Health Sciences Corporation. It is currently FDA-approved. Also known as: Pulmicort Turbuhaler 200 mcg.

Budesonide 400 mcg, marketed by Hamilton Health Sciences Corporation, is a well-established treatment in its class. The key composition patent is set to expire in 2028, providing a significant period of market exclusivity. The primary risk lies in potential competition from generic entries post-patent expiry.

At a glance

Generic namebudesonide 400 mcg
Also known asPulmicort Turbuhaler 200 mcg
SponsorHamilton Health Sciences Corporation
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about budesonide 400 mcg

What is budesonide 400 mcg?

budesonide 400 mcg is a Small molecule drug developed by Hamilton Health Sciences Corporation.

Who makes budesonide 400 mcg?

budesonide 400 mcg is developed and marketed by Hamilton Health Sciences Corporation (see full Hamilton Health Sciences Corporation pipeline at /company/hamilton-health-sciences-corporation).

Is budesonide 400 mcg also known as anything else?

budesonide 400 mcg is also known as Pulmicort Turbuhaler 200 mcg.

What development phase is budesonide 400 mcg in?

budesonide 400 mcg is FDA-approved (marketed).

Related